Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-01-12 @ 11:16 AM
Study NCT ID:
NCT02603705
Status:
COMPLETED
Last Update Posted:
2018-03-05
First Post:
2015-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Sponsor:
Egalet Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-10
First Submit QC Date:
None
Study First Post Date:
2015-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-02
Last Update Post Date:
2018-03-05
Last Update Post Date Type:
ACTUAL